Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
5 pending office actions • 5 art units • 4 examiners • 0 of 5 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Sansure Biotech Inc. currently manages 5 pending office actions in the Biotechnology & Pharmaceuticals technology area. These matters are distributed across 4 distinct examiners and 5 distinct art units. This distribution indicates that the company's intellectual property is being scrutinized by a variety of specialists across different divisions of the USPTO.
EDWARDS, LYDIA E is the busiest examiner for the company, holding 2 pending office actions. The remaining pending office actions are handled by the other distinct examiners. This concentration with a single examiner for a portion of the portfolio may allow for some consistency in prosecution strategy for those specific matters.
The portfolio's footprint across the distinct art units shows a high degree of specialization in the company's filings. This distribution suggests that each of the company's pending matters is being evaluated by a different specialized group within the USPTO, with the exception of the cases handled by the busiest examiner. Navigating 5 different art units requires a nuanced understanding of the specific examination trends and priorities within each group to successfully advance the pending office actions.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (20%) |
| §102 only | 1 (20%) |
| Multi-statute (no §101) | 3 (60%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| EDWARDS, LYDIA E | 2 | 60.1% | +6.0% |
| SINES, BRIAN J | 1 | 80.1% | +5.2% |
| LY, KRISTINA ELISABETH | 1 | 37.5% | +100.0% |
| BAUSCH, SARAE L | 1 | 29.7% | +45.0% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18681762 | COMPOSITON FOR LIQUEFYING VISCOUS BIOLOGICAL SAMPLE, COMBINTATION PRODUCT, LIQUEFYING AGENT, AND KIT THEREOF, AND METHOD AND APPLICATION THEREOF | SINES, BRIAN J | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17935281 | REAGENT COMBINATION AND KIT FOR DETECTING LIVER CANCERS, AND USE THEREOF | BAUSCH, SARAE L | 22d |
| 18431023 | DEVICE OF AUTOMATICALLY DETECTING NUCLEIC ACID AND METHOD OF AUTOMATICALLY DETECTING NUCLEIC ACID | EDWARDS, LYDIA E | — |
| 18404646 | MOLECULAR DETECTION SYSTEM AND DETECTION METHOD THEREOF | EDWARDS, LYDIA E | — |
| 18332805 | COMPOSITIONS, KITS, METHODS FOR DETECTING AND IDENTIFYING PATHOGENS THAT CAUSE RESPIRATORY TRACT INFECTIONS AND USE THEREOF | LY, KRISTINA ELISABETH | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17935281 | REAGENT COMBINATION AND KIT FOR DETECTING LIVER CANCERS, AND USE THEREOF | BAUSCH, SARAE L | 22d |
| 18332805 | COMPOSITIONS, KITS, METHODS FOR DETECTING AND IDENTIFYING PATHOGENS THAT CAUSE RESPIRATORY TRACT INFECTIONS AND USE THEREOF | LY, KRISTINA ELISABETH | — |
| Art Unit | Apps |
|---|---|
| 1682 | 1 |
| 1796 | 1 |
| 1681 | 1 |
| 1671 | 1 |
| 1699 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18681762 | COMPOSITON FOR LIQUEFYING VISCOUS BIOLOGICAL SAMPLE, COMBINTATION PRODUCT, LIQUEFYING AGENT, AND KIT THEREOF, AND METHOD AND APPLICATION THEREOF | SINES, BRIAN J | 1682 | §102 | Non-Final OA | — | Pending | Feb 06, 2024 |
| 18431023 | DEVICE OF AUTOMATICALLY DETECTING NUCLEIC ACID AND METHOD OF AUTOMATICALLY DETECTING NUCLEIC ACID | EDWARDS, LYDIA E | 1796 | §102§103§112 | Non-Final OA | — | Pending | Feb 02, 2024 |
| 18404646 | MOLECULAR DETECTION SYSTEM AND DETECTION METHOD THEREOF | EDWARDS, LYDIA E | 1681 | §102§103 | Non-Final OA | — | Pending | Jan 04, 2024 |
| 18332805 | COMPOSITIONS, KITS, METHODS FOR DETECTING AND IDENTIFYING PATHOGENS THAT CAUSE RESPIRATORY TRACT INFECTIONS AND USE THEREOF | LY, KRISTINA ELISABETH | 1671 | §103§112 | Non-Final OA | — | Pending | Jun 12, 2023 |
| 17935281 | REAGENT COMBINATION AND KIT FOR DETECTING LIVER CANCERS, AND USE THEREOF | BAUSCH, SARAE L | 1699 | §101§102§112 | Non-Final OA | 22d | Pending | Sep 26, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialSansure Biotech Inc. has 5 pending office actions as of October 2026, spread across 5 art units and 4 examiners.
Lydia E Edwards has the most, with 2 of Sansure Biotech Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
